Andon Health002432.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 19, 2026, Andon Health (002432.SZ) trades at a P/E of 5.61x, P/B of 1.08x, P/S of 23.30x, and a dividend yield of 2.79%.
Longitudinal percentile comparison: P/E sits at the 12th percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/B sits at the 24th percentile over the trailing 10Y window (vs. 61st percentile over 3Y); P/S sits at the 93rd percentile over the trailing 10Y window (vs. 77th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 0th percentile within its industry and the 1st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 6.63%, ranking at the 94th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 11.8 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 2.79% comes from cash dividends, with an implied ~3.84% from buybacks — a fairly balanced mix of both channels. Andon Health operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 002432 · SZSE: 002432 · 002432
Want the full picture on whether Andon Health (002432.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 5.61 | ||||||
| P/B (MRQ) | 1.08 | ||||||
| P/S (TTM) | 23.30 | ||||||
| Dividend Yield | 2.79% | ||||||
| Buyback + Div Yield | 6.63% |